Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.

Pharma firms like Lilly, Roche and Pfizer are racing to develop weight loss pills. Blockbuster injections ... Wegovy and Ozempic—for diabetes and firms like Lilly and Pfizer making progress ...

Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...

It revealed that sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion ... or by people sending in photos of themselves.

For many, weight loss injections like Wegovy and Mounjaro have felt like ... the most effective and high-dose injections saw their progress unravel fast. The weight came back almost twice as ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Both Wegovy and Mounjaro are given as weekly injections ... weight-loss jabs. The medication can no longer be dispensed to patients who have completed online questionnaires or sent photos.

While Mounjaro offers even greater weight-loss results, its premium price keeps it out of reach for most patients in Israel. Wegovy’s partial price reduction is undoubtedly progress, but it ...

Weight-loss drugs will be offered to millions of the most obese people on the NHS, to help them manage their health. Wegovy and Mounjaro jabs are currently only available from specialist weight ...